Regenxbio RGNX
NASDAQ RGNX
$8.94 -0.26 (-2.83%)
As of: Sep 4, 2026 · 3:59 PM EDT

Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025)

Regenxbio (RGNX) posted quarterly Amortizatization of Intangibles of $1.2 million for Q4 2025, up 10.03% year-over-year from $1.1 million in Q4 2024, and down 32.58% quarter-over-quarter from $1.8 million in Q3 2025.

Analysis

Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends

Regenxbio's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.2 million for Q4 2025.

  • In Q4 2025, Amortizatization of Intangibles rose 10.03% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $5.5 million (up 32.22% YoY), while the FY2025 annual figure was $5.5 million, up 32.22% from the prior year.
  • Amortizatization of Intangibles for Q4 2025 stood at $1.2 million, down from $1.8 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $1.8 million in Q3 2025, with the low at -$1.6 million in Q2 2021.
  • The 5-year median for Amortizatization of Intangibles is -$123500.0 (2023), against an average of -$80900.0.
  • The sharpest annual moves came in 2021 and 2024: Amortizatization of Intangibles sank 3202.56% in 2021, then soared 889.47% in 2024.
  • Regenxbio's Amortizatization of Intangibles stood at -$1.5 million in 2021, then surged by 38.36% to -$903000.0 in 2022, then soared by 126.8% to $242000.0 in 2023, then jumped by 361.57% to $1.1 million in 2024, then advanced by 10.03% to $1.2 million in 2025.
  • Business Quant data shows RGNX's Amortizatization of Intangibles at $1.2 million in Q4 2025, $1.8 million in Q3 2025, and $1.4 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Regenxbio 472.74 Mn 367.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.23 Mn
Sep 30, 2025 1.82 Mn
Jun 30, 2025 1.36 Mn
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.24 Mn
Mar 31, 2024 468,000.00
Dec 31, 2023 242,000.00
Sep 30, 2023 133,000.00
Jun 30, 2023 -380,000.00
Mar 31, 2023 -682,000.00
Dec 31, 2022 -903,000.00
Sep 30, 2022 -1.13 Mn
Jun 30, 2022 -1.22 Mn
Mar 31, 2022 -1.46 Mn
Dec 31, 2021 -1.47 Mn
Sep 30, 2021 -1.51 Mn
Jun 30, 2021 -1.58 Mn
Mar 31, 2021 -1.29 Mn